Sponsors dig into CapVest’s Curium ahead of initial bids 

JPM and Rothschild are providing financial advice to the nuclear medicine company.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this